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A number of isolates of Saccharomyces cerevisiae have been associated with disease
in immunocompromised individuals. Such isolates display a variety of characteristics
that enable colonization and persistence in the host. The aim of the work presented
here was to establish whether clinical isolates of S. cerevisiae were capable of
adhering to epithelial tissue. Adherence to host tissue has been shown to be crucial
to the virulence of the pathogenic yeast Candida albicans, and identication of this
ability in S. cerevisiae might indicate a role for adherence in tissue colonization by
this emerging pathogen. Clinical S. cerevisiae isolates were found to be capable of
adhering to exfoliated buccal epithelial cells (BECs) but to a lesser degree than C.
albicans. In contrast to the situation evident with C. albicans, the adherence of S.
cerevisiae isolates to BECs was not inuenced by the carbon source in which the
yeast was grown. Treatment of S. cerevisiaewith trypsin or proteinase K resulted in a
signicant reduction in adherence ability while adherence was unaffected by
treatment of cells with mannosidase, thus indicating a possible role for proteins
rather than mannoproteins in the adherence of S. cerevisiae to BECs.
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Introduction
Saccharomyces cerevisiae is used extensively in tradi-
tional (i.e. brewing, winemaking and baking) and
modern (i.e. for the production of recombinant proteins)
forms of biotechnology and as a dietary supplement.
There have been numerous reports of S. cerevisiae
inducing disease in both healthy and immunocompro-
mised individuals [1] and the yeast has been found in
many diverse body sites including the lungs [2–4], the
liver and blood [2], oesophagus, scrotum and urine [4]. S.
cerevisiae has also been found to be the aetiological
agent of vaginitis in a number of instances [5,6]. S.
cerevisiae has recently been upgraded from ‘generally
regarded as safe’ (GRAS) status to biosafety level one
(BSL-1) status [7].
Clinical isolates of S. cerevisiae exhibit several
virulence factors common to other pathogenic yeasts.
The ability of some S. cerevisiae isolates to grow at 42 oC
has been shown to be important since this allows survival
in the febrile host. Virulent isolates are capable of
producing protease, growing as pseudohyphae [8] and of
persisting and proliferating in the brains of CD-1 mice
[9].
Candida albicans is the most frequent cause of fungal
infection in humans and displays a variety of factors
including adherence to epithelial tissue [10], phenotypic
switching [11], production of phospholipase [12,13] and
secretory aspartyl proteases (SAPs) [14], and dimorph-
ism [10] which are considered to be important to the
success of the pathogenic process. Adherence to
epithelial tissue allows the yeast to colonize, penetrate
and invade host tissue and is achieved by a combination
of specic and non-specic mechanisms [15]. Due to the
importance of adherence to the pathogenicity of C.
albicans, an investigation into the potential of clinical
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isolates of S. cerevisiae adhering to epithelial tissue was
undertaken. Adherence could represent a novel viru-




S. cerevisiae CBS 1227 and CBS 1464 were obtained from
the Centraalbureau voor Schimmelcultures Yeast Divi-
sion (Delft, the Netherlands). S. cerevisiae yjm 128, yjm
145 and yjm 436 were donated by Dr Karl Clemons
(Santa Clara Valley Medical Center, San Diego, USA).
All the above strains are clinical isolates whose sources
have been described [9]. C. albicans ATCC 10231 was
obtained from the American Type Culture Collection
(Manassas, VA, USA). S. cerevisiae JJ1A (a arg¡, thr¡)
was provided by the Department of Genetics, Trinity
College Dublin, Ireland. A commercially available
Bakers’ yeast (BY) product (McDougalls Ltd., Hamp-
shire, UK) was also used.
Growth conditions
All cultures were grown at 30 oC overnight in 50 ml
YEPD broth (1% (w/v) yeast extract (Oxoid, Basing-
stoke, UK), 2% (w/v) bacteriological peptone (Oxoid)
and 2% (w/v) glucose (Sigma Chemical Co., Dorset,
UK)) in 100 ml conical asks in an orbital incubator at
200 rpm. Where used, sucrose (Sigma) (YEPSuc) and
galactose (Sigma) (YEPGal) replaced glucose at the
same concentration.
Adherence assay
Buccal epithelial cells (BECs) were collected from
healthy human volunteers using sterile tongue depres-
sors by gently rubbing the inside of the buccal cavity.
Cells were resuspended in 5 ml of phosphate-buffered
saline (PBS; pH 7¢4) (GibcoBRL, Paisley, UK). BECs
from four to ve volunteers were pooled, centrifuged in a
Beckman GS-6 centrifuge (760 g, 5 min, 18 oC) at 760 g
for 5 min, washed twice by centrifugation in sterile
PBS and resuspended in PBS at a concentration of
2 £ 105 cells ml¡1. Yeast cultures were grown to station-
ary phase overnight, harvested by centrifugation at
2100 g, washed twice with 5 ml PBS and resuspended
in PBS at a density of 1 £ 107 cells ml¡1. Yeast cell
suspension (1 ml) and BEC suspension (1 ml) were
pooled (giving a ratio of 50:1 yeast:BEC) and incubated
for 2 h at 30 oC and 200 rpm. BECs with adherent yeasts
were collected by ltering through a polycarbonate
membrane containing 12 mm pores and then washed
gently with 10 ml PBS in order to remove any non-
adhering yeast. BECs were collected in 2 ml PBS and
1 ml of this suspension was placed onto each of two glass
slides per treatment. These were allowed to air dry
overnight, heat-xed by passing through a bunsen ame
and stained for 30 s using 0¢5% (w/v) crystal violet
solution (Sigma). The number of yeasts adhering to each
of 200 BECs per treatment was determined microscopi-
cally. All assays were performed in duplicate on at least
two independent occasions and results calculated using
the SigmaStat (Jandel Corporation, Erkrath, Germany)
software programme. A Dunns t-test was performed to
establish whether a signicant difference existed be-
tween the treatments and control.
Enzymatic degradation of cell wall components
Trypsin (Sigma) was dissolved at 1 mg ml¡1 in sterile
PBS; proteinase K (Boehringer Mannheim, Germany)
was dissolved in PBS and used at a concentration of
1 mg ml¡1; and mannosidase (Sigma) was dissolved in
PBS and used at 1 mg ml¡1. Stationary phase yeast cells
were harvested by centrifugation, washed with 5 ml PBS
and resuspended at a density of 1 £ 107 cells ml¡1 in PBS
containing one of the above enzymes. Cells were
incubated in trypsin or proteinase K for 2 h at 30 oC
and 200 rpm. Cells were harvested by centrifugation,
washed with PBS and mixed with exfoliated BECs in a
ratio of 50:1. Adherence was measured as described.
In the case of the treatment of cells with mannosidase,
controls were resuspended in PBS and incubated at
30 oC and 200 rpm for 3 h prior to the adherence assay.
Cells to be treated with enzyme were resuspended in
PBS and incubated at 30 oC and 200 rpm. In the 1-h
treatment, the enzyme was added for the nal hour of
the incubation period, while in the 3-h treatment the
enzyme was added at the beginning of the incubation
period. In each case cells were incubated at 30 oC and
200 rpm for 3 h prior to the adherence assays being
performed.
Results
Adherence to host tissue has been established as a
critical factor in the pathogenicity of C. albicans [10].
The primary aim of the work presented here was to
establish whether clinical isolates of S. cerevisiae were
also capable of adhering to epithelial tissue. Yeast cells
were cultured as described and mixed with exfoliated
BECs at a ratio of 50:1 (yeast:BEC). Adherence of yeasts
to exfoliated BECs was assayed as described. The
adherence of S. cerevisiae cells to BECs compared to
that of C. albicans 10231 can be seen in Figure 1. In the
case of all the clinical S. cerevisiae isolates, adherence is
signicantly greater (P < 0¢05) than that of S. cerevisiae
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JJ1A and Baker’s yeast, but less than that of C. albicans.
The clinical S. cerevisiae isolates demonstrate adherence
levels of between 43 and 74% that of C. albicans with
strain 145 exhibiting the highest adherence level.
Previous investigations into factors affecting the
adherence of C. albicans have shown that the level of
adherence to epithelial tissue is inuenced by the carbon
source in which the yeast is cultured [16,17]. C. albicans
10231, a commercially available Bakers’ yeast product
and four of the clinical S. cerevisiae isolates (1227, 1464,
128 and 436) were grown to the stationary phase in
YEPD, YEPGal or YEPSuc and adherence assays were
performed as described. The results indicate that C.
albicans cells grown in galactose or sucrose exhibit
elevated levels of adherence (Fig. 2). Bakers’ yeast
manifested low levels of adherence when grown in
glucose but greatly increased levels were evident when
cells were cultured in galactose or sucrose (Fig. 2). S.
cerevisiae 1227 exhibited no signicant (P < 0¢05)
change in adherence ability regardless of the carbon
source, showing levels similar to that of the control C.
albicans isolate when grown in glucose medium. The
other three S. cerevisiae isolates (1464, 128 and 436) also
displayed no signicant change (P < 0¢05) in adherence
ability when cultured in the different growth media.
Elements of the C. albicans cell wall, including
proteins and mannoproteins, have been implicated in
adherence of the yeast to host tissue [18]. A number of
cell surface-modifying agents were employed against S.
cerevisiae in order to establish the relative importance of
the major cell wall components in the adherence process.
Stationary phase yeast cells were harvested, washed and
incubated in PBS containing trypsin (1 mg ml¡1) at
30 oC and 200 rpm for 2 h. Cells were subsequently
washed twice in 5 ml PBS prior to pooling with BECs at
a ratio of 50:1 (yeast:BECs). The results (Table 1)
indicate that C. albicans exhibited a 64% reduction in
adherence to BECs when treated with trypsin. Treat-
ment of Bakers’ yeast with trypsin reduced the adher-
ence ability by approximately 78%. Three of the clinical
S. cerevisiae isolates (1227, 1464 and 128) showed
reductions in adherence ability of between 47 and 84%
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Fig. 1 Adherence of yeast isolates to exfoliated buccal epithelial
cells (BECs). Adherence of yeast isolates was determinedby mixing
yeasts and BECs (50:1) and incubating for 2 h at 30 oC and 200 rpm.
Data are the mean adherence §SE.
Fig. 2 Effect of carbon source on the adherence of yeast isolates
to buccal epithelial cells (BECs). Yeasts were grown to the
stationary phase in YEPD, YEPGal or YEPSuc. Adherence assays
were performed as described. Data are the mean adherence §SE.
Table 1 Effect of trypsin and proteinase K on the adherence ability of yeast isolates to buccal epithelial cells (BECs)
Trypsin 1mg ml¡1 Proteinase K 1mg ml¡1
Control cells Treated cells Control cells Treated cells
C. albicans 10231 2¢47 § 0¢14 0¢92 § 0¢08 1¢17 § 0¢08 0¢64 § 0¢06
S. cerevisiae BY 1¢16 § 0¢09 0¢61 § 0¢07 0¢99 § 0¢10 0¢22 § 0¢03
S. cerevisiae 1227 1¢45 § 0¢09 0¢23 § 0¢03 0¢58 § 0¢04 0¢20 § 0¢03
S. cerevisiae 1464 1¢92 § 0¢08 0¢46 § 0¢04 0¢49 § 0¢02 0¢14 § 0¢05
S. cerevisiae 128 0¢96 § 0¢10 0¢50 § 0¢05 0¢27 § 0¢03 0¢18 § 0¢02
S. cerevisiae 436 1¢10 § 0¢10 1¢08 § 0¢12 0¢76 § 0¢08 0¢57 § 0¢07
Data are the mean number of yeast adhering to a single BEC cell § SE.
Stationary phase yeast cells were treated with trypsin or proteinase K for 2 h at 30 oC and 200 rpm. Cells were harvested by centrifugation, washed












when exposed to trypsin. Only isolate 436 showed no
signicant reduction in adherence capability after treat-
ment with this enzyme.
Pre-treatment of yeast cells with proteinase K for 2 h
at 30 oC produced a 45% reduction in adherence of C.
albicans to BECs (Table 1). A reduction of 78% in
adherence ability was observed when Baker’s yeast was
treated with proteinase K and all the clinical S. cerevisiae
isolates treated with this enzyme showed reductions in
adherence ranging from 25% to approximately 70%.
Stationary phase yeast cells were treated with manno-
sidase for 1 or 3 h before being harvested by centrifuga-
tion, washed and mixed with BECs. The results of these
assays (Table 2) indicate a decrease in C. albicans
adherence to BECs of approximately 60% after 1 h but
no further signicant change (P < 0¢05) after 3 h
exposure to mannosidase. Treatment of S. cerevisiae
1227 with mannosidase for 1 h produced no reduction in
adherence although a slight inhibition was evident after
three hours exposure. S. cerevisiae isolates 1464, 128 and
436 exposed to mannosidase for 3 h showed no reduction
in adherence ability but may have displayed a small
elevation in adherence ability to BECs. Similarly, the
treatment of Bakers’ yeast with mannosidase for 3 h may
have resulted in a slight increase in adherence ability.
Discussion
Adherence is crucial to the pathogenicity of C. albicans
[10] and is mediated by receptor-ligand interactions
[19,20] and non-specic factors [21]. The aim of the work
presented here was to establish whether isolates of S.
cerevisiae that had been implicated in cases of disease
were capable of adhering to epithelial tissue since this
could represent a previously uncharacterized virulence
factor.
Clinical S. cerevisiae isolates adhered to exfoliated
BECs but to a lesser extent than C. albicans 10231. C.
albicans 10231 and Bakers’ yeast showed signicant
increases in adherence ability when cultured in galactose
or sucrose while the adherence of clinical S. cerevisiae
isolates to BECs showed no signicant change when
cultured in different carbon sources. The nature of the
carbon source has been shown previously to have a
profound effect on the adherence ability of C. albicans to
BECs [16] and cultured cells [22] and has been linked to
changes in the yeast cell surface, particularly in the
production and secretion of mannoprotein, a putative
adhesin associated with the brillar layer of the cell
surface [23]. This work indicates that while the adher-
ence of Bakers’ yeast to BECs is inuenced by the nature
of the carbon source used for growth this effect is not
evident in clinical S. cerevisiae isolates.
Modication of cell wall proteins using either trypsin
or proteinase K (Table 1) resulted in signicant
reductions in adherence of clinical S. cerevisiae isolates
to BECs. Only S. cerevisiae 436 showed no change in
adherence ability when treated with trypsin. Proteinase
K treatment reduced the adherence of clinical S.
cerevisiae isolates from 25 to 65%. Mannoproteins play
an important role in the adherence of C. albicans to host
tissue [18]. The treatment of C. albicans with mannosi-
dase caused a substantial decrease (60%) in adherence
to BECs. S. cerevisiae 1227 exhibited a small decrease in
adherence following treatment with mannosidase for 3 h
while no signicant reduction was observed with isolates
1464, 128 and 436. Previous work has demonstrated that
S. cerevisiae mannan is insensitive to the action of
mannosidase [24]. The results presented here may
indicate some degree of heterogeneity in the suscepti-
bility to this enzyme among clinical S. cerevisiae isolates.
Cell wall proteins seem to play an important role in the
adherence ability of clinical S. cerevisiae isolates and
mannoproteins do not have as important a role as
evident in C. albicans. Flocculation in brewing strains of
S. cerevisiae can be reduced substantially by treatment of
cells with protease indicating that cell surface associated
proteins are important in mediating cell–cell interactions
leading to oc formation [25]. Similar proteins may play
a role in the adherence of clinical S. cerevisiae isolates to
BECs.
Proteins which have been identied as potential
adhesins in C. albicans include the products of the
ALS1 gene [26] and the ALA1 gene [27]. The ALS1
gene has extensive homology to the S. cerevisiae gene
AGa1 which produces an agglutination protein [26]. The
expresion of the AGa1 protein product may be
enhanced in clinical S. cerevisiae isolates thus mediating
adherence. Clinical isolates of S. cerevisiae have been
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Table 2 Effect of mannosidase on the adherence ability of yeast
isolates to buccal epithelial cells (BECs)
Mannosidase 1mg ml¡1
Control cells 1-h samples 3-h samples
C. albicans 10231 2¢57 § 0¢12 1¢03 § 0¢07 0¢95 § 0¢07
S. cerevisiae BY 1¢33 § 0¢10 1¢10 § 0¢11 1¢49 § 0¢14
S. cerevisiae 1227 1¢71 § 0¢09 1¢70 § 0¢08 1¢02 § 0¢08
S. cerevisiae 1464 0¢66 § 0¢06 ND 0¢82 § 0¢08
S. cerevisiae 128 0¢75 § 0¢08 ND 0¢96 § 0¢10
S. cerevisiae 436 0¢68 § 0¢06 0¢92 § 0¢07 0¢81 § 0¢07
Data are the mean number of yeast cells adhering to a single BEC cell § SE.
Stationary phase yeast cells were treated with mannosidase for 1 or 3 h at
30 oC and 200 rpm. Cells were harvested by centrifugation, washed with PBS
and resuspended with BECs at a ratio of 50:1. Adherence was measured as












shown previously to be capable of aggregating and
blocking capillaries in experimental models [9]. This
suggests that cells must have some ability to adhere to
one another and/or to the capillary wall. Several Candida
species and clinical S. cerevisiae isolates have been
examined for integrin expression [20] and it was found
that clinical isolates of S. cerevisiae exhibited low levels
of integrin analogue expression but demonstrated some
ability to adhere to a cervical epithelial cultured cell line
(Hela S3).
Clinical isolates of S. cerevisiae show signicantly
greater levels of adherence to exfoliated BECs when
cultured in YEPD compared to a laboratory S. cerevisiae
isolate (JJ1A) and Baker’s yeast (P < 0¢05) but levels of
adherence for all clinical isolates were less than that of
C. albicans 10231. The ability of clinical S. cerevisiae
isolates to adhere to epithelial cells may represent a
novel virulence factor. In particular, adherence may be
important in cases where the vagina [5,6] or oropharynx
[28] are colonized by this yeast. Adherence to epithelial
tissue has previously been shown to be crucial for the
successful colonization of these body sites by C. albicans
[15]. The results presented here suggest that S. cerevisiae
adherence appears to be mediated by adhesins which are
proteinaceous in nature and this may indicate that
proteins associated with aggregation or occulation are
involved in facilitating adherence to epithelial tissue.
Adherence may assist in the colonization of tissue by S.
cerevisiae in vivo.
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